Receptor BioLogix, Inc. is a biopharmaceutical company focused on the development and commercialization of a newly discovered class of protein therapeutics called Intron Fusion Proteins (IFP) to treat cancer, autoimmune, metabolic and other diseases.
3350 West Bayshore Road
Palo Alto, 94303
California, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)